SynthesisFrontiers in immunology2021

Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis.

Qing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.